Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: Synta Pharmaceuticals Corp

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Synta Pharmaceuticals Corp in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Synta Pharmaceuticals Corp since year 2005. Table 2 shows the detailed insider transactions of Synta Pharmaceuticals Corp since 2005. The reporting company's ticker symbol is SNTA. The reporting company's CIK number is 1157601.

The total value of stock buying since 2005 is $12,272,661. The total value of stock sales is $0. The total value of stock exercises is $0.


1 year stock price chart,   1 day stock price chart
opopp
opopopop

Figure 1. Monthly insider transaction values at Synta Pharmaceuticals Corp (SNTA) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • $10,005k

    $1,000k

    $100k

    $10k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at Synta Pharmaceuticals Corp (SNTA) in the past 24 months. See table 2 for insider transaction details.

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • $10.00

    $7.50

    $5.00

    $2.50



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Synta Pharmaceuticals Corp (SNTA).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-08 143,397 1,067,297 0 0 0 0
2008-05 80,000 567,133 0 0 0 0
2007-11 5,000 39,140 0 0 0 0
2007-06 70,467 594,091 0 0 0 0
2007-02 1,000,500 10,005,000 0 0 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for Synta Pharmaceuticals Corp (SNTA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-08-13 Gollust Keith R Purchase 31,997 7.78 248,827
2008-08-12 Kovner Bruce Purchase 1,300 7.37 9,579
2008-08-12 Gollust Keith R Purchase 35,000 7.58 265,251
2008-08-11 Kovner Bruce Purchase 25,100 7.15 179,470
2008-08-11 Gollust Keith R Purchase 50,000 7.28 364,170
2008-05-30 Gollust Keith R Purchase 5,939 7.10 42,163
2008-05-29 Gollust Keith R Purchase 24,061 7.18 172,709
2008-05-19 Gollust Keith R Purchase 10,000 6.95 69,473
2008-05-16 Gollust Keith R Purchase 40,000 7.07 282,788
2007-11-26 Bahcall Safi R (President and CEO) Purchase 5,000 7.83 39,140
2007-06-11 Kovner Bruce (Director) Purchase 34,600 8.57 296,646
2007-06-08 Kovner Bruce (Director) Purchase 35,867 8.29 297,445
2007-02-09 Williams Martin D (Sr. VP, Business Dev., CBO) Purchase 200 10.00 2,000
2007-02-09 Jacobson Eric W (Sr. VP, Research and CMO) Purchase 300 10.00 3,000
2007-02-09 Kovner Bruce Purchase 720,000 10.00 7,200,000
2007-02-09 Gollust Keith R Purchase 180,000 10.00 1,800,000
2007-02-09 Wilson Robert N Purchase 100,000 10.00 1,000,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Synta Pharmaceuticals Corp (symbol SNTA, CIK number 1157601) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.